Legal & General Group PLC Bio N Tech Se Transaction History

Legal & General Group PLC

$390 Billion
Q2 2025

A detailed history of Legal & General Group PLC transactions in Bio N Tech Se stock. As of the latest transaction made, Legal & General Group PLC holds 315,748 shares of BNTX stock, worth $32.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

315,748

Previous 253,460 24.58%

Holding current value

$32.8 Million

Previous $23.1 Million 45.65%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$86.65 - $120.54 $5.4 Million - $7.51 Million	62,288 Added 24.58%	315,748 $33.6 Million
Q1 2025 May 15, 2025	BUY	$91.06 - $126.88 $542,626 - $756,077	5,959 Added 2.41%	253,460 $23.1 Million
Q4 2024 Feb 13, 2025	BUY	$99.72 - $122.68 $3.41 Million - $4.2 Million	34,226 Added 16.05%	247,501 $28.2 Million
Q3 2024 Feb 28, 2025	SELL	$78.36 - $124.66 $2.78 Million - $4.42 Million	-35,434 Reduced 14.32%	212,067 $25.2 Million
Q3 2024 Nov 14, 2024	BUY	$78.36 - $124.66 $715,896 - $1.14 Million	9,136 Added 4.48%	213,275 $25.3 Million
Q2 2024 May 29, 2025	BUY	$80.36 - $102.87 $2.63 Million - $3.37 Million	32,759 Added 19.25%	202,931 $16.3 Million
Q2 2024 Aug 14, 2024	BUY	$80.36 - $102.87 $2.67 Million - $3.41 Million	33,192 Added 19.42%	204,139 $16.4 Million
Q1 2024 May 29, 2025	SELL	$88.96 - $112.35 $7.41 Million - $9.36 Million	-83,288 Reduced 32.86%	170,172 $15.7 Million
Q1 2024 May 14, 2024	BUY	$88.96 - $112.35 $1.15 Million - $1.45 Million	12,921 Added 8.18%	170,947 $15.8 Million
Q4 2023 May 29, 2025	SELL	$90.91 - $112.75 $8.68 Million - $10.8 Million	-95,434 Reduced 37.65%	158,026 $16.7 Million
Q4 2023 Feb 15, 2024	BUY	$90.91 - $112.75 $2.02 Million - $2.5 Million	22,182 Added 16.33%	158,026 $16.7 Million
Q3 2023 Nov 14, 2023	BUY	$98.5 - $125.08 $727,915 - $924,341	7,390 Added 5.75%	135,844 $14.8 Million
Q2 2023 Aug 14, 2023	BUY	$102.58 - $129.66 $2.74 Million - $3.46 Million	26,718 Added 26.26%	128,454 $13.9 Million
Q1 2023 May 15, 2023	BUY	$122.57 - $153.67 $886,793 - $1.11 Million	7,235 Added 7.66%	101,736 $12.7 Million
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $378,383 - $594,429	3,195 Added 3.5%	94,501 $14.2 Million
Q3 2022 Nov 14, 2022	BUY	$127.65 - $183.11 $1.74 Million - $2.5 Million	13,656 Added 17.59%	91,306 $12.3 Million
Q2 2022 Aug 22, 2022	BUY	$123.25 - $186.24 $2.2 Million - $3.33 Million	17,885 Added 29.93%	77,650 $11.6 Million
Q1 2022 May 16, 2022	BUY	$126.25 - $231.85 $3.6 Million - $6.61 Million	28,493 Added 91.11%	59,765 $10.2 Million
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $1.03 Million - $1.73 Million	4,769 Added 17.99%	31,272 $7.62 Million
Q3 2021 Nov 15, 2021	BUY	$205.93 - $447.23 $1.72 Million - $3.73 Million	8,333 Added 45.86%	26,503 $7.33 Million
Q2 2021 Aug 12, 2021	SELL	$113.32 - $241.49 $2.87 Million - $6.11 Million	-25,301 Reduced 58.2%	18,170 $4.06 Million
Q1 2021 May 17, 2021	SELL	$85.73 - $119.5 $39,178 - $54,611	-457 Reduced 1.04%	43,471 $4.75 Million
Q4 2020 Feb 12, 2021	BUY	$72.71 - $129.54 $3.19 Million - $5.69 Million	43,928 New	43,928 $3.58 Million

Others Institutions Holding BNTX

# of Institutions

320

Shares Held

40.7M

Call Options Held

1.39M

Put Options Held

1.52M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $25.2B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Bio N Tech Se Transaction History